Avastin filed for glioblastoma in Japan after official prod
This article was originally published in Scrip
Executive Summary
Prompted by a government request, Roche's Japanese subsidiary Chugai has filed for the approval in Japan of Avastin (bevacizumab) for the additional indication of recurrent glioblastoma.